Cargando…

Treatment of Alzheimer’s disease in Brazil: I. Cognitive disorders

This article reports the recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology for the treatment of Alzheimer’s disease (AD) in Brazil, with special focus on cognitive disorders. It constitutes a revision and broadening of the 2005 guidel...

Descripción completa

Detalles Bibliográficos
Autores principales: do Vale, Francisco de Assis Carvalho, Corrêa Neto, Ylmar, Bertolucci, Paulo Henrique Ferreira, Machado, João Carlos Barbosa, da Silva, Delson José, Allam, Nasser, Balthazar, Márcio Luiz Figueredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Neurologia Cognitiva e do Comportamento 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619477/
https://www.ncbi.nlm.nih.gov/pubmed/29213742
http://dx.doi.org/10.1590/S1980-57642011DN05030005
_version_ 1783267413492498432
author do Vale, Francisco de Assis Carvalho
Corrêa Neto, Ylmar
Bertolucci, Paulo Henrique Ferreira
Machado, João Carlos Barbosa
da Silva, Delson José
Allam, Nasser
Balthazar, Márcio Luiz Figueredo
author_facet do Vale, Francisco de Assis Carvalho
Corrêa Neto, Ylmar
Bertolucci, Paulo Henrique Ferreira
Machado, João Carlos Barbosa
da Silva, Delson José
Allam, Nasser
Balthazar, Márcio Luiz Figueredo
author_sort do Vale, Francisco de Assis Carvalho
collection PubMed
description This article reports the recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology for the treatment of Alzheimer’s disease (AD) in Brazil, with special focus on cognitive disorders. It constitutes a revision and broadening of the 2005 guidelines based on a consensus involving researchers (physicians and non-physicians) in the field. The authors carried out a search of articles published since 2005 on the MEDLINE, LILACS and Cochrane Library databases. The search criteria were pharmacological and non-pharmacological treatment of cognitive disorders in AD. Studies retrieved were categorized into four classes, and evidence into four levels, based on the 2008 recommendations of the American Academy of Neurology. The recommendations on therapy are pertinent to the dementia phase of AD. Recommendations are proposed for the treatment of cognitive disorders encompassing both pharmacological (including acetyl-cholinesterase inhibitors, memantine and other drugs and substances) and non-pharmacological (including cognitive rehabilitation, physical activity, occupational therapy, and music therapy) approaches. Recommendations for the treatment of behavioral and psychological symptoms of dementia due to Alzheimer’s disease are included in a separate article of this edition.
format Online
Article
Text
id pubmed-5619477
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Associação de Neurologia Cognitiva e do Comportamento
record_format MEDLINE/PubMed
spelling pubmed-56194772017-12-06 Treatment of Alzheimer’s disease in Brazil: I. Cognitive disorders do Vale, Francisco de Assis Carvalho Corrêa Neto, Ylmar Bertolucci, Paulo Henrique Ferreira Machado, João Carlos Barbosa da Silva, Delson José Allam, Nasser Balthazar, Márcio Luiz Figueredo Dement Neuropsychol Views & Reviews This article reports the recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology for the treatment of Alzheimer’s disease (AD) in Brazil, with special focus on cognitive disorders. It constitutes a revision and broadening of the 2005 guidelines based on a consensus involving researchers (physicians and non-physicians) in the field. The authors carried out a search of articles published since 2005 on the MEDLINE, LILACS and Cochrane Library databases. The search criteria were pharmacological and non-pharmacological treatment of cognitive disorders in AD. Studies retrieved were categorized into four classes, and evidence into four levels, based on the 2008 recommendations of the American Academy of Neurology. The recommendations on therapy are pertinent to the dementia phase of AD. Recommendations are proposed for the treatment of cognitive disorders encompassing both pharmacological (including acetyl-cholinesterase inhibitors, memantine and other drugs and substances) and non-pharmacological (including cognitive rehabilitation, physical activity, occupational therapy, and music therapy) approaches. Recommendations for the treatment of behavioral and psychological symptoms of dementia due to Alzheimer’s disease are included in a separate article of this edition. Associação de Neurologia Cognitiva e do Comportamento 2011 /pmc/articles/PMC5619477/ /pubmed/29213742 http://dx.doi.org/10.1590/S1980-57642011DN05030005 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Views & Reviews
do Vale, Francisco de Assis Carvalho
Corrêa Neto, Ylmar
Bertolucci, Paulo Henrique Ferreira
Machado, João Carlos Barbosa
da Silva, Delson José
Allam, Nasser
Balthazar, Márcio Luiz Figueredo
Treatment of Alzheimer’s disease in Brazil: I. Cognitive disorders
title Treatment of Alzheimer’s disease in Brazil: I. Cognitive disorders
title_full Treatment of Alzheimer’s disease in Brazil: I. Cognitive disorders
title_fullStr Treatment of Alzheimer’s disease in Brazil: I. Cognitive disorders
title_full_unstemmed Treatment of Alzheimer’s disease in Brazil: I. Cognitive disorders
title_short Treatment of Alzheimer’s disease in Brazil: I. Cognitive disorders
title_sort treatment of alzheimer’s disease in brazil: i. cognitive disorders
topic Views & Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619477/
https://www.ncbi.nlm.nih.gov/pubmed/29213742
http://dx.doi.org/10.1590/S1980-57642011DN05030005
work_keys_str_mv AT dovalefranciscodeassiscarvalho treatmentofalzheimersdiseaseinbrazilicognitivedisorders
AT correanetoylmar treatmentofalzheimersdiseaseinbrazilicognitivedisorders
AT bertoluccipaulohenriqueferreira treatmentofalzheimersdiseaseinbrazilicognitivedisorders
AT machadojoaocarlosbarbosa treatmentofalzheimersdiseaseinbrazilicognitivedisorders
AT dasilvadelsonjose treatmentofalzheimersdiseaseinbrazilicognitivedisorders
AT allamnasser treatmentofalzheimersdiseaseinbrazilicognitivedisorders
AT balthazarmarcioluizfigueredo treatmentofalzheimersdiseaseinbrazilicognitivedisorders
AT treatmentofalzheimersdiseaseinbrazilicognitivedisorders